Kim K S, Kang J H, Concepcion N F, Anthony B F
Infect Immun. 1986 Jun;52(3):908-10. doi: 10.1128/iai.52.3.908-910.1986.
Human immunoglobulin G (IgG) separated from whole serum by a quaternary aminoethyl-Sephadex A-50 ion exchanger was evaluated for its activity against a type III group B streptococcal strain in the newborn rat model. Separated IgG yielded approximately 70 to 80% of whole serum IgG and did not contain detectable IgM or IgA. This IgG preparation also contained similar ratios of specific type III group B streptococcal antibody to total IgG in comparison with whole serum. In vivo, 50% protection from death was achieved by 3.9 ng of type III-specific antibody per 10 g of rat body weight. This value was considerably lower than 50% protective doses obtained in our previous studies with different human IgG preparations. Further studies are needed to understand the mechanisms responsible for these differences in the functional activity of IgG antibody.
通过季胺乙基 - 葡聚糖凝胶A - 50离子交换剂从全血清中分离出的人免疫球蛋白G(IgG),在新生大鼠模型中针对III型B族链球菌菌株的活性进行了评估。分离出的IgG产生了全血清IgG的约70%至80%,且不含有可检测到的IgM或IgA。与全血清相比,该IgG制剂中特定III型B族链球菌抗体与总IgG的比例也相似。在体内,每10克大鼠体重3.9纳克的III型特异性抗体可实现50%的死亡保护。该值远低于我们之前使用不同人IgG制剂研究中获得的50%保护剂量。需要进一步研究以了解造成IgG抗体功能活性这些差异的机制。